Cargando…
Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
We describe a 51‐year‐old otherwise healthy woman hospitalized for hypotension, fever, and weakness 4 days after the second‐dose Covid‐19 mRNA vaccine. Elevated inflammatory markers, natriuretic peptide levels and troponin levels, and slightly reduced left ventricular ejection fraction of 50% were n...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053174/ https://www.ncbi.nlm.nih.gov/pubmed/36417910 http://dx.doi.org/10.1002/ehf2.14252 |
_version_ | 1785015349699149824 |
---|---|
author | Kobayashi, Kosuke Hamatani, Yasuhiro Moriyoshi, Koki Iguchi, Moritake Masunaga, Nobutoyo Terashima, Mariko Abe, Mitsuru Sasahashi, Nozomu Akao, Masaharu |
author_facet | Kobayashi, Kosuke Hamatani, Yasuhiro Moriyoshi, Koki Iguchi, Moritake Masunaga, Nobutoyo Terashima, Mariko Abe, Mitsuru Sasahashi, Nozomu Akao, Masaharu |
author_sort | Kobayashi, Kosuke |
collection | PubMed |
description | We describe a 51‐year‐old otherwise healthy woman hospitalized for hypotension, fever, and weakness 4 days after the second‐dose Covid‐19 mRNA vaccine. Elevated inflammatory markers, natriuretic peptide levels and troponin levels, and slightly reduced left ventricular ejection fraction of 50% were noted. We also found the multiple organ damage, including mucocutaneous, gastrointestinal, and neurologic systems. In addition, we revealed the positive results for anti‐nucleocapsid SARS‐CoV‐2 IgG, albeit negative for SARS‐CoV‐2 polymerase chain reaction testing, suggesting the prior asymptomatic Covid‐19 infection. We finally diagnosed her as multisystem inflammatory syndrome after vaccination. Of note, we obtained myocardial specimen from the patients and demonstrated the lymphohistiocytic myocarditis, which is a rare form of myocarditis. |
format | Online Article Text |
id | pubmed-10053174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100531742023-03-30 Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman Kobayashi, Kosuke Hamatani, Yasuhiro Moriyoshi, Koki Iguchi, Moritake Masunaga, Nobutoyo Terashima, Mariko Abe, Mitsuru Sasahashi, Nozomu Akao, Masaharu ESC Heart Fail Case Reports We describe a 51‐year‐old otherwise healthy woman hospitalized for hypotension, fever, and weakness 4 days after the second‐dose Covid‐19 mRNA vaccine. Elevated inflammatory markers, natriuretic peptide levels and troponin levels, and slightly reduced left ventricular ejection fraction of 50% were noted. We also found the multiple organ damage, including mucocutaneous, gastrointestinal, and neurologic systems. In addition, we revealed the positive results for anti‐nucleocapsid SARS‐CoV‐2 IgG, albeit negative for SARS‐CoV‐2 polymerase chain reaction testing, suggesting the prior asymptomatic Covid‐19 infection. We finally diagnosed her as multisystem inflammatory syndrome after vaccination. Of note, we obtained myocardial specimen from the patients and demonstrated the lymphohistiocytic myocarditis, which is a rare form of myocarditis. John Wiley and Sons Inc. 2022-11-23 /pmc/articles/PMC10053174/ /pubmed/36417910 http://dx.doi.org/10.1002/ehf2.14252 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Kobayashi, Kosuke Hamatani, Yasuhiro Moriyoshi, Koki Iguchi, Moritake Masunaga, Nobutoyo Terashima, Mariko Abe, Mitsuru Sasahashi, Nozomu Akao, Masaharu Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman |
title | Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman |
title_full | Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman |
title_fullStr | Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman |
title_full_unstemmed | Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman |
title_short | Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman |
title_sort | multisystem inflammatory syndrome and lymphohistiocytic myocarditis after covid‐19 vaccine in a middle‐aged woman |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053174/ https://www.ncbi.nlm.nih.gov/pubmed/36417910 http://dx.doi.org/10.1002/ehf2.14252 |
work_keys_str_mv | AT kobayashikosuke multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman AT hamataniyasuhiro multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman AT moriyoshikoki multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman AT iguchimoritake multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman AT masunaganobutoyo multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman AT terashimamariko multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman AT abemitsuru multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman AT sasahashinozomu multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman AT akaomasaharu multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman |